跳转至内容
Merck
CN
搜索范围
语言
主题
内容物类型
集合
主题范围
产品分类
应用

591-97-9

应用筛选条件
关键词:'591-97-9'
显示 1-10 #N/A 920 条结果 关于 "591-97-9" 范围 网站内容
Sodium acetate buffer solution for molecular biology
Sodium Acetate Buffer provider. 5+ decades providing high-quality buffer products that maintain consistent performance for molecular biology .
X-tremeGENE™ 9 DNA Transfection Reagent Protocol
Plate cells approx. 24 hours before transfection making sure cells are at optimal concentration (70 – 90 % confluency).
CRISPR Cas 9 Nuclease RNA-guided Genome Editing
Learn about CRISPR Cas9, what it is and how it works. CRISPR is a new, affordable genome editing tool enabling access to genome editing for all.
Color Determination of sugar based on ICUMSA Color GS2-9
Learn about the ICUMSA® Method GS2-9 (2024) to measure the color of sample solutions of white sugar or highly pure sugar syrup of color index up to 600 IU.
X-tremeGENE™ 9 DNA转染试剂实验方案
约转染前24小时接种细胞,确保细胞处于最佳密度(7090 %融合度)。
LC/MS Analysis of Phospholipids in Milk on Asc
(soybean), ≥97%; L-α-Phosphatidylethanolamine from egg yolk, Type III, ≥97% (TLC), lyophilized powder; L-α-Phosphatidylcholine, from egg yolk, Type XVI-E, ≥99% (TLC), lyophilized powder; Sphingomyelin, from chicken egg yolk, ≥95%
Merck Expands in Gillingham, UK, Boosts Distribution Capabilities
Merck today announced the completion of a £9 million expansion to its Gillingham distribution center.
胃肠道癌症中的免疫组织化学应用
结直肠癌是男性和女性中第三大常见癌症。预计2016年将发生136,000例结直肠癌。
Accelerated mAb Development Program – From Transfection to GMP Drug Substance in 9 Months
The accelerated mAb development program delivers GMP drug substance nine months from transfection. We designed the mAbExpress™ program to be fast, cost effective, and appropriate for the early clinical phase of your program, with regulatory support throughout.
How to Boost AAV Titer with Feed Supplementation in both HEK293 and Sf-9 Platforms
In this webinar, you will learn wow to boost AAV titers in HEK293 and Sf-9 cell lines as well as getting some insider tips on volume and timing optimization.
1/92